6 hrs ago | PR-inside.com
Zacks Analyst Blog Highlights: Research In Motion, Apple, Palm, GlaxoSmithKline Plc and Merck
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets.
14 hrs ago | Blogging Stocks
Don't believe the headline hype on Alcoa
Filed under: Earnings reports , Alcoa Inc Aluminum producer Alcoa Inc. , the first Dow Jones Industrial Component to report earnings, beat estimates when they announced after the bell -- or so the story goes.
22 hrs ago | Market Wire
Addex Achieves Second Milestone in Parkinson's Disease Collaboration with Merck & Co., Inc.
Allosteric modulation company Addex Pharmaceuticals announced today that the second preclinical milestone has been achieved in an exclusive collaboration and license agreement with Merck & Co., Inc.
Yesterday | The Oregonian
Merck HIV drug Isentress gets full US approval
The Food and Drug Administration said Thursday it has approved expanded use of a Merck & Co.
US stocks edged higher on Thursday as investors bought beaten-down technology and commodity shares, while a positive broker comment on Goldman Sachs boosted the financial sector.
Continue reading "Merck, Portola in $470 million deal for anticlotting drug"
Merck & Co. and Portola Pharmaceuticals Inc. said Thursday they have signed an exclusive deal to develop and market an experimental drug to prevent strokes in people with a dangerous irregular heart rhythm.
WHO approves cervical cancer vaccine Cervarix, donors can buy doses for poor countries
The World Health Organization has approved a second cervical cancer vaccine, this one made by GlaxoSmithKline, meaning U.N. agencies and partners can now officially buy millions of doses of the vaccine for poor countries worldwide.
Monthly Pet Pill Could Kill Ticks, Fleas
THURSDAY, July 2 a ' Controlling ticks and fleas is drudgery for countless pet owners.
Johnson & Johnson Inflames Abbott
Since 2002, David and Tom Gardner have returned 30.96% while the S&P 500 returned -10.28%. Try Stock Advisor free for 30 days.
Since 2002, David and Tom Gardner have returned 30.96% while the S&P 500 returned -10.28%. Try Stock Advisor free for 30 days.
Monthly pet pill could kill fleas, ticks
Controlling ticks and fleas is drudgery for countless pet owners. Now, researchers report they're closer to developing a monthly pill that would conveniently rid cats and dogs of these disease-carrying invaders.
Merck invests $65 million in Puerto Rico expansion
BARCELONETA, Puerto Rico - Drugmaker Merck, Sharp & Dohme Ltd. has announced a $65 million expansion of its pharmaceutical laboratories in Puerto Rico.
Bay Group Sues Over River Pollution Limits
The Chesapeake Bay Foundation is challenging a Virginia State Water Control Board decision that allows Merck & Co.
CHMP Recommends 'Januvia(R)'(sitagliptin), From MSD, For Restricted First Line Use In European Union
Merck & Co., Inc. , which operates in many countries as Merck Sharp & Dohme , has received a positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use recommending restricted first line use of 'Januvia' for the treatment of type 2 diabetes.
BOND INVESTORS ARE VERY COMFORTABLE with Merck, but equity investors are less enthusiastic, judging from the high dividend yield of 6% on the drug maker's shares.
Supply of Key Children's Vaccine Almost Back to Normal
A children's vaccine that's been in short supply for 18 months is now being produced at levels that allow its traditional widespread use, officials at the U.S. Centers for Disease Control and Prevention announced Thursday.
Merck launches Phase III study of Stimuvax in breast cancer
The study will determine if Stimuvax can extend progression-free survival in patients treated with hormonal therapy who have hormone receptor-positive, locally advanced, recurrent or metastatic breast cancer.
Merck & Co., Inc. And Drugs For Neglected Diseases Initiative...
Main Category: Tropical Diseases Also Included In: Infectious Diseases / Bacteria / Viruses Article Date: 24 Jun 2009 On the eve of an international meeting bringing together 200 African researchers to discuss progress on research for neglected tropical diseases , Merck & Co., Inc.
Merck Issues $4.25 Billion of Notes in U.S. Drugmaker's Biggest Bond Sale
Merck & Co. sold $4.25 billion of bonds in a four-part offering, its biggest ever, to finance the acquisition of rival drugmaker Schering-Plough Corp.
Merck Selling $4.25 Billion In Debt
Merck & Co. is selling $4.25 billion in debt Monday, with portions maturing from 2 years to 30 years, according to Informa Global Markets.